Johns Hopkins Medical Institutions
Viagra's other talents: Help a 'signaling' protein shield the heart from high blood pressure damage
Published in Hematology Week, January 19th, 2009
The team's findings, to be published in the Journal of Clinical Investigation online Jan. 5, helps explain why sildenafil, more widely known as Viagra, has already been shown to improve heart function and may one day have value in either treating or preventing heart damage due to chronic high blood pressure.
The key, investigators say, is sildenafil's effects on a single protein, RGS2, newly identified in the latest study as an essential link in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2009-01-19)
More Articles from Hematology Week
- BioMed Central
Metabolic syndrome risk for veterans with PTSD - New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Simple model predicts those at risk for chronic kidney disease - World Journal of Gastroenterology
The prevalence of gluten-sensitive enteropathy in iron-deficient anemia patients - Advanced Cell Technology, Inc.
Functional Vasculature Generated From Advanced Cell Technology’s Human Embryonic Stem Cells - Apoptosis
Reports summarize apoptosis research from University of Quebec - Blood Substitutes
Research on blood substitutes described by scientists at Ohio State University - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
